Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bioelectronics Corp BIEL

BioElectronics Corporation is an electroceutical company. The Company develops wearables, neuromodulation devices to mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) that uses low power pulsed electromagnetic fields regulate electrical activity of the nervous system. Its product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and... see more

Recent & Breaking News (PINL:BIEL)

BioElectronics' ActiPatch(R) Nonprescription Medical Device That Reduces Pain 52% and Medication Use 50% including Opioids

Marketwired December 12, 2016

BioElectronics Appoints Southeast Asia Distributor

Marketwired November 1, 2016

BioElectronics President Interviewed by the StockRadio.com Discusses BioElectronics, the Science of the Chronic Pain market, and Drug Use

Marketwired October 27, 2016

BioElectronics Comments on its U.S. FDA's OTC Market Clearance Application

PR Newswire October 10, 2016

BioElectronics Submits Back Pain Relief & Medication Use Side Effects Registry Study for Publication

PR Newswire September 28, 2016

Small Healthcare Companies Sometimes Forgotten

PR Newswire May 27, 2016

BioElectronics Engages Adam Staelin As Executive Vice President of Sales and Marketing

PR Newswire May 11, 2016

BioElectronics Responds to U.S. FDA's Comments on its Market Clearance Application

PR Newswire May 10, 2016

BioElectronics' Drug-free ActiPatch® Pain Therapy

PR Newswire April 28, 2016

BioElectronics' ActiPatch® Chronic Pain Therapy Featured In UK's Leading Daily Mail Newspaper Health Section

PR Newswire April 25, 2016

BioElectronics President Interviewed by the StockRadio.com

PR Newswire April 11, 2016

BioElectronics Drug-free Chronic Pain Therapy Observation Study Results

PR Newswire March 29, 2016

BioElectronics Appoints Evomed as Australian and New Zealand Distributor

PR Newswire March 21, 2016

BioElectronics Wins "Best OTC Marketing Campaign on a Small Budget"

PR Newswire March 15, 2016

BioElectronics Invited to Present Chronic Pain Patient Observation Study at the British Pain Society Congress

PR Newswire March 9, 2016

BioElectronics and B. Braun Medical Ltd Apply for Prescription Payment Clearance on the UK Drug Tariff

PR Newswire February 18, 2016

BioElectronics Corporation Refutes SEC Order for Administrative Proceedings

PR Newswire February 8, 2016

BioElectronics' Innovative Chronic Pain Therapy Nominated for "Best OTC Marketing Campaign on a Small Budget"

PR Newswire February 1, 2016

BioElectronics Announces Publication of Breakthrough Clinical Study for Drug-free Treatment of Chronic Osteoarthritis

PR Newswire January 5, 2016

BioElectronics Announces Oxford University Sponsored Study

PR Newswire December 14, 2015